Home › Funds › TANG CAPITAL MANAGEMENT LLC › IMCR

TANG CAPITAL MANAGEMENT LLC position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 2,649,368 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q2 2026 13F filing — a position valued at US$84.1M, representing 3.82% of its reported portfolio and ranking #13 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed IMCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.65M sh
Reported value held$84.12M
Portfolio Weight3.82%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's IMCR position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in IMCR in Q3 2023 at 405,600 shares (US$21.1M). The position peaked in Q4 2025 at 2,628,538 shares, worth US$91.2M. Across 12 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 2,649,368 shares valued at US$84.1M. Notable position changes include a 173% increase in Q3 2024 (shares fell 5% over the following quarter), a 41% increase in Q4 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 405.60K $21.05M New
Q4 2023 405.60K $27.71M Hold
Q1 2024 405.60K $26.36M Hold
Q2 2024 405.60K $13.75M Hold
Q3 2024 1.11M $34.42M Add
Q4 2024 1.56M $45.89M Add
Q1 2025 1.92M $56.84M Add
Q2 2025 2.11M $66.07M Add
Q3 2025 2.31M $83.76M Add
Q4 2025 2.63M $91.24M Add
Q1 2026 2.65M $79.88M Add
Q2 2026 2.65M $84.12M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 31 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), Vestal Point Capital, LP (US$57.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held IMCR?

TANG CAPITAL MANAGEMENT LLC has disclosed IMCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TANG CAPITAL MANAGEMENT LLC's current position in IMCR?

As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 2.65M shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $84.12M, representing 3.82% of its reported portfolio and ranking #13.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling IMCR?

In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in IMCR. The position peaked in Q4 2025 at 2.63M shares.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, Vestal Point Capital, LP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.